Group 1: Lululemon Athletica - Lululemon Athletica is experiencing margin compression despite growth, leading to price target reductions from analysts [1][3] - The current stock price is $239.29, with a 12-month price forecast of $340.26, indicating a potential upside of 42.20% [1][2] - The company maintains an 18% operating margin, supporting a healthy balance sheet and business investment [3] Group 2: UnitedHealth Group - UnitedHealth Group's stock has faced significant declines due to regulatory, legal, and margin issues, resulting in drastic price target reductions [5][6] - The current stock price is $308.22, with a 12-month price forecast of $426.52, suggesting a potential upside of 38.38% [5][6] - Institutional ownership is high at approximately 87%, with solid buying activity in Q2, indicating potential stability [8] Group 3: Enphase Energy - Enphase Energy is challenged by potential cuts to subsidies for alternative energy under the Trump administration, impacting revenue and earnings outlook [10][11] - The current stock price is $33.80, with a 12-month price forecast of $67.07, indicating a potential upside of 98.41% [10] - Institutional interest is significant, with over 70% ownership, but recent selling trends suggest a continued downtrend unless favorable news emerges [12]
Lululemon, UNH, Enphase: Bad News, Good Opportunity?